SCHEMBL5551907

SCHEMBL5551907

CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.74
LMNA P02545 1/20 0.74
USP2 O75604 2/20 0.56
ABCB1 P08183 2/20 0.56
KCNH2 Q12809 3/20 0.34
MLNR O43193 4/20 0.32
TP53 P04637 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
AR P10275 1/20 0.31
MAPK1 P28482 1/20 0.31
SLCO1B3 Q9NPD5 1/20 0.31
SLCO1B1 Q9Y6L6 1/20 0.31
ATP1A1 P05023 1/20 0.31
ATP1B1 P05026 1/20 0.31
ATP1A3 P13637 1/20 0.31
ATP1B2 P14415 1/20 0.31
ATP1A2 P50993 1/20 0.31
ATP1B3 P54709 1/20 0.31
FXYD2 P54710 1/20 0.31
ATP1A4 Q13733 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleandomycin SCHEMBL29684259 0.86 CYP3A4 (1.00) CYP3A4LMNAUSP2ABCB1KCNH2
Oleandomycin SCHEMBL10028439 0.86 CYP3A4 (1.00) CYP3A4LMNAUSP2ABCB1KCNH2
Oleandomycin SCHEMBL3716 0.86 CYP3A4 (1.00) CYP3A4LMNAUSP2ABCB1KCNH2
Oleandomycin SCHEMBL3717 0.86 CYP3A4 (1.00) CYP3A4LMNAUSP2ABCB1KCNH2
Oleandomycin SCHEMBL9807053 0.85 CYP3A4 (0.99) CYP3A4LMNAUSP2ABCB1KCNH2
Oleandomycin SCHEMBL950913 0.84 CYP3A4 (0.96) CYP3A4LMNAUSP2ABCB1KCNH2
Oleandomycin SCHEMBL285338 0.83 CYP3A4 (1.00) CYP3A4LMNAUSP2ABCB1KCNH2
Oleandomycin SCHEMBL5033021 0.83 CYP3A4 (1.00) CYP3A4LMNAUSP2ABCB1KCNH2
SCHEMBL2619140 0.80 CYP3A4 (0.55) CYP3A4LMNAUSP2ABCB1
SCHEMBL3439708 0.78 CYP3A4 (0.51) CYP3A4LMNAUSP2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013619-B1 METHODS FOR USING HUMAN EMBRYONIC STEM CELLS TO EVALUATE TOXICITY OF PHARMACEUTICAL COMPOUNDS & OTHER CHEMICALS WISCONSIN ALUMNI RES FOUND (US) 2017-10-11 EP disclosed
US-20140255969-A1 REAGENTS AND METHODS FOR USING HUMAN EMBRYONIC STEM CELLS TO EVALUATE TOXICITY OF PHARMACEUTICAL COMPOUNDS AND OTHER CHEMICALS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-09-11 US disclosed
US-8703483-B2 Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds and other chemicals WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-04-22 US disclosed
US-20070248947-A1 Reagents and Methods for Using Human Embryonic Stem Cells to Evaluate Toxicity of Pharmaceutical Compounds and Other Chemicals WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2007-10-25 US disclosed